Host expression of methylmalonyl-CoA mutase and tuberculosis: A missing link?

Medical Hypotheses

Volumn 76, Issue 3, 2011, Pages 361-364

  de la Fuente, José ^a,b   Gortazar, Christian ^a   Vicente, Joaquín ^a   Villar, Margarita ^a  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHOLESTEROL; METHYLMALONYL COENZYME A MUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; BOVINE TUBERCULOSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; HEREDITY; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; MYCOBACTERIUM BOVIS; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; TUBERCULOSIS; WILD BOAR;

ANIMALS; CATTLE; CHOLESTEROL; HUMANS; METHYLMALONYL-COA MUTASE; MODELS, BIOLOGICAL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; SUS SCROFA; TUBERCULOSIS; TUBERCULOSIS, BOVINE;

ANIMALIA; BOVINAE; CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; SUS SCROFA;

EID: 79751523912     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.10.040     Document Type: Article

References (50)

1. Smith R.M., Drobniewski F., Gibson A., Montague J.D., Logan M.N., et al. Mycobacterium bovis infection, United Kingdom. Emerg Infect Dis 2004, 10:539-541.
2. Naranjo V., Gortazar C., Vicente J., de la Fuente J. Evidence of the role of European wild boar as a reservoir of tuberculosis due to Mycobacterium tuberculosis complex. Vet Microbiol 2008, 127:1-9.
3. Cosivi O., Grange J.M., Daborn C.J., Raviglione M.C., Fujikura T., et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 1998, 4:59-70.
4. Michel A.L., Müller B., van Helden P.D. Mycobacterium bovis at the animal-human interface: a problem, or not?. Vet Microbiol 2010, 140:371-381.
5. de Kantor I.N., Ambroggi M., Poggi S., Morcillo N., Da Silva Telles M.A., et al. Human Mycobacterium bovis infection in ten Latin American countries. Tuberculosis 2008, 88:358-365.
6. Amanfu W. The situation of tuberculosis and tuberculosis control in animals of economic interest. Tuberculosis 2006, 86:330-335.
7. Gortázar C., Torres M.J., Vicente J., Acevedo P., Reglero M., et al. Bovine tuberculosis in Doñana Biosphere Reserve: the role of wild ungulates as disease reservoirs in the Last Iberian Lynx Strongholds. PLoS ONE 2008, 3:e2776.
8. Martín-Hernando M.P., Höfle U., Vicente J., Ruiz-Fons F., Vidal D., et al. Lesions associated with Mycobacterium tuberculosis complex infection in the European wild boar. Tuberculosis 2007, 87:360-367.
9. Bolin C.A., Whipple D.L., Khanna K.V., Risdahl J.M., Peterson P.K., et al. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J Infect Dis 1997, 176:1559-1566.
10. Parrish N., Dick J., Bishai W. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998, 6:107-112.
11. Buddle B.M., Wedlock D.N., Denis M. Progress in the development of tuberculosis vaccines for cattle and wildlife. Vet Microbiol 2006, 112:191-200.
12. Ballesteros C., Pérez de la Lastra J.M., de la Fuente J. Recent developments in oral bait vaccines for wildlife. Recent Patents Drug Deliv Formul 2007, 1:230-235.
13. Ballesteros C., Garrido J.M., Vicente J., Romero B., Galindo R.C., et al. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. Vaccine 2009, 27:6662-6668.
14. Fine P.E. The BCG story: lessons from the past and implications for the future. Rev Infect Dis 1989, 11(Suppl. 2):S353-S359.
15. Hope J.C., Villarreal-Ramos B. Bovine TB and the development of new vaccines. Comp Immunol Microbiol Infect Dis 2008, 31:77-100.
16. Pérez-Guzmán C., Vargas M.H. Hypocholesterolemia: a major risk factor for developing pulmonary tuberculosis. Med Hypotheses 2006, 66:1227-1230.
17. Erol A. Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for metabolic syndrome. Med Hypotheses 2008, 71:222-228.
18. Clark-Curtiss J.E., Haydel S.E. Molecular genetics of Mycobacterium tuberculosis pathogenesis. Annu Rev Microbiol 2003, 57:517-549.
19. Koul A., Herget T., Klebl B., Ullrich A. Interplay between mycobacteria and host signalling pathways. Nat Rev Microbiol 2004, 2:189-202.
20. Gatfield J., Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 2000, 288:1647-1650.
21. Pandey A.K., Sassetti C.M. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci USA 2008, 105:4376-4380. Erratum in: Proc Natl Acad Sci USA 2008; 105: 9130.
22. Sim E., Sandy J., Evangelopoulos D., Fullam E., Bhakta S., et al. Arylamine N-acetyltransferases in mycobacteria. Curr Drug Metab 2008, 9:510-519.
23. Schäfer G., Guler R., Murray G., Brombacher F., Brown G.D. The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model. PLoS One 2009, 4:e8448.
24. Miner M.D., Chang J.C., Pandey A.K., Sassetti C.M., Sherman D.R. Role of cholesterol in Mycobacterium tuberculosis infection. Indian J Exp Biol 2009, 47:407-411.
25. 12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids. J Bacteriol 2008, 190:3886-3895.
26. Brzostek A., Pawelczyk J., Rumijowska-Galewicz A., Dziadek B., Dziadek J. Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol 2009, 191:6584-6591.
27. Hunter R.L., Olsen M., Jagannath C., Actor J.K. Trehalose 6, 6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol 2006, 168:1249-1261.
28. Muñoz S., Rivas-Santiago B., Enciso J.A. Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand J Immunol 2009, 70:256-263.
29. Kim D.K., Kim H.J., Kwon S.Y., Yoon H.I., Lee C.T., et al. Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J 2008, 32:1031-1036.
30. Martens G.W., Arikan M.C., Lee J., Ren F., Vallerskog T., et al. Hypercholesterolemia impairs immunity to tuberculosis. Infect Immun 2008, 76:3464-3472.
31. Abba K., Sudarsanam T.D., Grobler L., Volmink J. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2008, 4:CD006086.
32. Deniz O., Gumus S., Yaman H., Ciftci F., Ors F., et al. Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis. Clin Biochem 2007, 40:162-166.
33. Shope R.E. The quantity of cholesterol in the blood serum of the guinea pig as an inherited character; its relation to natural resistance to tuberculosis, and to tuberculosis infection. J Exp Med 1927, 45:59-68.
34. Vidal D., Naranjo V., Mateo R., Gortazar C., de la Fuente J. Analysis of serum biochemical parameters in relation to Mycobacterium bovis infection of European wild boars (Sus scrofa) in Spain. Eur J Wild Res 2006, 52:301-304.
35. Shope R.E. The influence of cholesterol on experimental tuberculosis. J Exp Med 1928, 48:321-337.
36. Naranjo V., Höfle U., Vicente J., Martín M.P., Ruiz-Fons F., et al. Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and non-tuberculous European wild boars naturally exposed to Mycobacterium bovis. FEMS Immunol Med Microbiol 2006, 46:298-312.
37. Naranjo V., Villar M., Martín-Hernando M.P., Vidal D., Höfle U., et al. Proteomic and transcriptomic analyses of differential stress/inflammatory responses in mandibular lymph nodes and oropharyngeal tonsils of European wild boars naturally infected with Mycobacterium bovis. Proteomics 2007, 7:220-231.
38. Naranjo V., Gortazar C., Villar M., de la Fuente J. Comparative genomics and proteomics to study tissue-specific response and function in natural Mycobacterium bovis infections. Anim Health Res Rev 2007, 8:81-88.
39. Galindo R.C., Ayoubi P., Naranjo V., Gortazar C., Kocan K.M., et al. Gene expression profiles of European wild boar naturally infected with Mycobacterium bovis. Vet Immunol Immunopathol 2009, 129:119-125.
40. Jansen R., Kalousek F., Fenton W.A., Rosenberg L.E., Ledley F.D. Cloning of full-length methylmalonyl-CoA mutase from a cDNA library using the polymerase chain reaction. Genomics 1989, 4:198-205.
41. Nham S.U., Wilkemeyer M.F., Ledley F.D. Structure of the human methylmalonyl-CoA mutase (MUT) locus. Genomics 1990, 8:710-716.
42. Kambo A., Sharma V.S., Casteel D.E., Woods V.L., Pilz R.B., et al. Nitric oxide inhibits mammalian methylmalonyl-CoA mutase. J Biol Chem 2005, 280:10073-10082.
43. 12 trafficking in mammals: a for coenzyme escort service. ACS Chem Biol 2006, 1:149-159.
44. Phillips C.J., Foster C.R., Morris P.A., Teverson R. Genetic and management factors that influence the susceptibility of cattle to Mycobacterium bovis infection. Anim Health Res Rev 2002, 3:3-13.
45. Fernando S.L., Britton W.J. Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol 2006, 84:125-137.
46. Acevedo-Whitehouse K., Vicente J., Gortazar C., Höfle U., Fernández de Mera I.G., et al. Genetic resistance to bovine tuberculosis in the Iberian wild boar. Mol Ecol 2005, 14:3209-3217.
47. Naranjo V., Ayoubi P., Vicente J., Ruiz-Fons F., Gortazar C., et al. Characterization of selected genes upregulated in non-tuberculous European wild boar as possible correlates of resistance to Mycobacterium bovis infection. Vet Microbiol 2006, 116:224-231.
48. Pérez de la Lastra J.M., Galindo R.C., Gortázar C., Ruiz-Fons F., de la Fuente J. Expression of immunoregulatory genes in peripheral blood mononuclear cells of European wild boar immunized with BCG. Vet Microbiol 2009, 134:334-339. Corrigendum: Vet Microbiol 2009; 139: 209-10.
49. Naranjo V., Acevedo-Whitehouse A., Vicente J., Gortazar C., de la Fuente J. Influence of methylmalonyl-CoA mutase alleles on resistance to bovine tuberculosis in the European wild boar (Sus scrofa). Anim Genet 2008, 39:316-320.
50. Kondo E., Kanai K. A suggested role of a host-parasite lipid complex in mycobacterial infection. Jpn J Med Sci Biol 1976, 29:199-210.